Faculty Pages - Dr. Jospeh M. Herman

Joseph M. Herman,M.D.

Education:

1994	B.S. - Biology Salisbury State University Salisbury, Maryland
1997	M.S. - Epidemiology and Preventive Medicine University of Maryland at Baltimore Baltimore, Maryland
2000	M.D. University of Maryland School of Medicine Baltimore, Maryland
2001	Post Doctoral Internship - Internal Medicine University of Michigan Health System Ann Arbor, Michigan
2001-04	Residency - Radiation Oncology University of Michigan Health System Ann Arbor, Michigan

Honors/Awards:

1994	Letter of Commendation, National Institutes of Health, Neurogenetics Section
1995	Graduate Merit Award, UMAB Master of Science in Preventive Medicine
1997	Awarded STRTP NIH grant to develop an IFA assay for HHV-8 and Kaposi’s Sarcoma
2000	Outstanding Student Achievement Award in Radiation Oncology and Pathology
2001	Awarded Intern of the Month, University of Michigan Internal Medicine

Selected References:

Publications
1. Tayebi N, Herman J, et al. Different recombinational events between the GC gene and pseudogene in patients with type 1, 2, and 3 Gaucher disease. A J Hum Genet. 1995; 57(4):1329.

2. Sidransky E, Tayebi N, Herman J, et al. Genotypic and phenotypic heterogeneity in type 2 Gaucher disease. Am J Hum Genet. 1995; 57(4):1453.

3. Tayebi N, Stern H, Dymarskaia I, Herman J, et al. 55 Base pair deletion in certain patients with Gaucher disease complicates screening for Gaucher alleles. Am J Med Genet. 1996; 66:316-319.

4. Tayebi N, Herman J, et al. Genotype D399/R463C in a patient with type 3 Gaucher disease previously assigned genotype N370/R463C. Biochem Mol Med. 1996; 57:149-151.

5. Solomon G, Huddle A, Silbergeld E, Herman J. Manganese in Gasoline: Are we repeating history? New Solutions. 1997; Winter:17-24.

6. Edelman D, Ketema F, Saville R, Herman J, Blattner W, et al. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J. Clinical Virology. 2000; 16(3):225-37.

7. Suntharalingam M.H., Conley M.L., Egorin B.A., Levy M.H., Sivasailam S., Herman J.M., et al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2000; 47(1):49-56.

8. Nwokedi E.C., DiBiase S.J., Jabbour S, Herman J, et al. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery. 2002; 50(1):41-46.

9. Petit J, Herman J, et al. Radiosurgical treatment of trigeminal neuralgia: evaluating quality of life and treatment outcomes. Int J Radiat Oncol Biol Phys. 2003; 56(4):1147-53.

10. Herman J, Smith D, Sandler H, et al. Quality of Life (QOL) assessment in patients receiving concurrent Gemcitabine and radiotherapy as a bladder preservation strategy. Urology. 2004; Jul 64(1):69-73.

11. Herman J, Petit J, et al. Repeat Gamma Knife Radiosurgery for Refractory or Recurrent Trigeminal Neuralgia: Treatment Outcomes and Quality of Life Assessment. Int J Rad Oncol Biol Phys. 2004; 59(1):112-116.

12. Kent E, Montie J, Lee C, Sandler H, Herman J, et al. Combined-modality therapy with Gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. J Clin Oncol. 2004; Jul 22(13):2540-5.

13. Cheuk, A., Chin, L., Petit, J., Herman, J., et al. Imaging correlates of gamma knife outcome in trigeminal neuralgia. Int J Rad Oncol Biol Phys. 60(2): 537-41, 2004.

14. Alexander, B, Wechsler, D, Braun, T, Levine, J, Herman, J, Yanik, G, Hutchinson, R, Pierce, L. Utility of Cranial Boost in Addition to Total Body Irradiation in the Treatment of High Risk Acute Lymphoblastic Leukemia. Int J Rad Oncol Biol Phys. 63(4):1191-1196, 2005.

15. McLaughlin, Narayana, V, Pan, C, Berri, S, Troyer, S, Herman J, et al. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds. Int J Rad Oncol Biol Phys. 64(1): 144-150, 2006.